Add BrightSurf on Google Email

Research opens up new avenue for Tuberculosis drug discovery

Scientists from the University of Bath have identified two new families of chemical compounds that inhibit alpha-methylacyl-CoA racemase (MCR) in Mycobacterium tuberculosis, a key enzyme for TB survival. This breakthrough could lead to new treatments for TB and potentially other diseases like prostate cancer.

SourceUniversity of Bath·JournalJournal of Biological Chemistry·TypeExperimental study·DateJul 2, 2025

Finding the enzymatic needle in the database haystack

A Kobe University team developed a technique to classify thousands of enzymes, allowing for rapid evaluation and identification of highly active and versatile enzymes. The approach enabled the discovery of an enzyme with up to 10 times higher productivity than industry standards.

SourceKobe University·JournalACS Catalysis·TypeExperimental study·DateJun 26, 2025